Giovanna Schiavoni Selected Research

Giovanna Schiavoni Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 02/2011
8	Melanoma (Melanoma, Malignant) 01/2021 - 12/2012
6	Infections 01/2020 - 05/2002
4	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2012
3	Hypersensitivity (Allergy) 01/2018 - 09/2013
2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Asthma (Bronchial Asthma) 01/2022 - 01/2017
1	Lymphoma (Lymphomas) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Necrosis 01/2018
1	Carcinogenesis 09/2016
1	Colorectal Neoplasms (Colorectal Cancer) 11/2015
1	Atherosclerosis 01/2015
1	Experimental Melanoma 01/2013
1	Tuberculosis (Tuberculoses) 01/2013
1	Granuloma 01/2013
1	Contact Dermatitis (Eczema, Contact) 03/2004
1	Asymptomatic Diseases 05/2003
1	Carotid Artery Diseases 05/2003

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2022 - 05/2002
5	AntibodiesIBA 10/2020 - 05/2003
5	Interleukin-33IBA 01/2020 - 09/2013
5	AntigensIBA 09/2016 - 03/2004
5	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 10/2014 - 12/2012
4	AlarminsIBA 01/2022 - 01/2018
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2011
4	Interferon Type IIBA 01/2018 - 02/2011
3	Pharmaceutical PreparationsIBA 10/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2003
3	ChemokinesIBA 10/2019 - 12/2012
3	Transcription Factors (Transcription Factor)IBA 10/2014 - 01/2013
2	matrigelIBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2003
2	AllergensIBA 01/2017 - 09/2013
2	Decitabine FDA Link 01/2017 - 12/2012
2	Immunoglobulins (Immunoglobulin)IBA 09/2016 - 05/2003
2	Interferon Regulatory FactorsIBA 10/2014 - 01/2013
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	atezolizumabIBA 10/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2019
1	Granzymes (Granzyme)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	IntegrinsIBA 10/2019
1	Biological ProductsIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	AldehydesIBA 01/2018
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	Cancer VaccinesIBA 09/2016
1	LigandsIBA 11/2015
1	AnthracyclinesIBA 11/2015
1	Therapeutic UsesIBA 11/2015
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 11/2015
1	Fibrinogen (Factor I)FDA Link 01/2015
1	InterleukinsIBA 01/2015
1	C-Reactive ProteinIBA 01/2015
1	Histocompatibility Antigens Class IIBA 12/2013
1	Chemokine ReceptorsIBA 12/2012
1	Interleukin-27 (Interleukin 27)IBA 12/2012
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 06/2006
1	Interferon gamma ReceptorIBA 06/2006

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2021 - 02/2011
5	Immunotherapy 10/2020 - 09/2016
3	Lab-On-A-Chip Devices 01/2020 - 11/2015
1	Sublingual Administration 01/2021
1	Therapeutics 01/2020
1	Intravenous Injections 01/2017
1	Intranasal Administration 01/2017
1	Adjuvant Chemotherapy 11/2015
1	Carotid Endarterectomy 05/2003